首页 > 最新文献

The Journal of dermatology最新文献

英文 中文
Clinical and laboratory features between anti‐TIF1γ dermatomyositis with and without malignancy: 37 case series and a review 抗TIF1γ皮肌炎伴有和不伴有恶性肿瘤的临床和实验室特征:37个病例系列和综述
Pub Date : 2024-09-11 DOI: 10.1111/1346-8138.17426
Ke‐yun Tang, Han‐lin Zhang, Xin‐yi Zhang, Hong‐zhong Jin
We aimed to analyze the clinical profile and malignancy indicators in dermatomyositis (DM) with anti‐transcriptional intermediary factor 1 antibody (anti‐TIF1γ‐Ab). A comparison was made between clinical information of anti‐TIF1γ DM patients with and without malignancy. Additionally, a review of the literature on anti‐TIF1γ DM and malignancy was conducted by searching PubMed and EMBASE databases. In our cohort of 37 patients, 27.0% (10/37) developed malignancy. The timeframe during which these 10 patients developed malignancy ranged from 21 months prior to the diagnosis of DM to 36 months following the diagnosis of DM. Specifically, one patient was diagnosed with breast cancer at the age of 36. Comparing the groups with and without malignancy, we found that age over 65 years (40% vs 7.4%, P = 0.035), a shorter duration from the onset of symptoms to the diagnosis of DM (2.5 vs 10 months, P = 0.003), and higher erythrocyte sedimentation rate (ESR) levels (23 vs 10 mm/h, P = 0.048) were found to be associated with an increased risk of malignancy. Conversely, the presence of Gottron's papules (63% vs 20%, P = 0.029) may suggest a lower likelihood of malignancy. The literature review revealed that the prevalence of myositis‐associated malignancy was 40.7% (340/836), with variations ranging from 19% to 82.9% across different series. In summary, factors such as age over 65 years, a shorter duration between symptom onset and diagnosis of DM, and elevated ESR levels may indicate an increased risk of malignancy in anti‐TIF1γ DM patients.
我们旨在分析皮肌炎(DM)患者抗转录中间因子1抗体(抗TIF1γ-Ab)的临床概况和恶性肿瘤指标。比较了有恶性肿瘤和无恶性肿瘤的抗TIF1γ DM患者的临床信息。此外,还通过检索 PubMed 和 EMBASE 数据库,对抗 TIF1γ DM 和恶性肿瘤的相关文献进行了综述。在我们的 37 例患者中,27.0%(10/37)发生了恶性肿瘤。这10名患者罹患恶性肿瘤的时间范围从DM诊断前的21个月到DM诊断后的36个月不等。其中,一名患者在 36 岁时被诊断出患有乳腺癌。比较有恶性肿瘤和没有恶性肿瘤的组别,我们发现年龄超过 65 岁(40% vs 7.4%,P = 0.035)、从出现症状到确诊为 DM 的时间较短(2.5 vs 10 个月,P = 0.003)、红细胞沉降率(ESR)水平较高(23 vs 10 mm/h,P = 0.048)与恶性肿瘤风险增加有关。相反,出现戈特龙丘疹(63% 对 20%,P = 0.029)可能表明恶性肿瘤的可能性较低。文献综述显示,肌炎相关恶性肿瘤的发病率为 40.7%(340/836),不同系列的发病率从 19% 到 82.9% 不等。总之,年龄超过65岁、从症状出现到诊断为DM的时间较短、ESR水平升高等因素可能预示着抗TIF1γ DM患者发生恶性肿瘤的风险增加。
{"title":"Clinical and laboratory features between anti‐TIF1γ dermatomyositis with and without malignancy: 37 case series and a review","authors":"Ke‐yun Tang, Han‐lin Zhang, Xin‐yi Zhang, Hong‐zhong Jin","doi":"10.1111/1346-8138.17426","DOIUrl":"https://doi.org/10.1111/1346-8138.17426","url":null,"abstract":"We aimed to analyze the clinical profile and malignancy indicators in dermatomyositis (DM) with anti‐transcriptional intermediary factor 1 antibody (anti‐TIF1γ‐Ab). A comparison was made between clinical information of anti‐TIF1γ DM patients with and without malignancy. Additionally, a review of the literature on anti‐TIF1γ DM and malignancy was conducted by searching PubMed and EMBASE databases. In our cohort of 37 patients, 27.0% (10/37) developed malignancy. The timeframe during which these 10 patients developed malignancy ranged from 21 months prior to the diagnosis of DM to 36 months following the diagnosis of DM. Specifically, one patient was diagnosed with breast cancer at the age of 36. Comparing the groups with and without malignancy, we found that age over 65 years (40% vs 7.4%, <jats:italic>P</jats:italic> = 0.035), a shorter duration from the onset of symptoms to the diagnosis of DM (2.5 vs 10 months, <jats:italic>P</jats:italic> = 0.003), and higher erythrocyte sedimentation rate (ESR) levels (23 vs 10 mm/h, <jats:italic>P</jats:italic> = 0.048) were found to be associated with an increased risk of malignancy. Conversely, the presence of Gottron's papules (63% vs 20%, <jats:italic>P</jats:italic> = 0.029) may suggest a lower likelihood of malignancy. The literature review revealed that the prevalence of myositis‐associated malignancy was 40.7% (340/836), with variations ranging from 19% to 82.9% across different series. In summary, factors such as age over 65 years, a shorter duration between symptom onset and diagnosis of DM, and elevated ESR levels may indicate an increased risk of malignancy in anti‐TIF1γ DM patients.","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142176790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of disease burden in patients with hereditary angioedema from Japan by patient‐reported outcomes 通过患者报告结果分析日本遗传性血管性水肿患者的疾病负担
Pub Date : 2024-09-11 DOI: 10.1111/1346-8138.17421
Michihiro Hide, Miwa Kishimoto, Ippei Kotera, Akinori Oh, Yoichi Inoue, Beverley Anne Yamamoto, Shinichi Noto
Hereditary angioedema (HAE) symptoms can vary greatly. Disease burden evaluation is essential for providing adequate treatments for patients. Patient‐reported outcome measures (PROMs), including the 12‐Item Short Form Health Survey (SF‐12), the Angioedema Quality of Life (AE‐QoL), the Hospital Anxiety and Depression Scale (HADS), and the Work Productivity and Activity Impairment: Specific Health Problem (WPAI:SHP) questionnaires, were collected in 2021, before modern medications for long‐term prophylaxis (LTP) of HAE were licensed in Japan. Patients also reported their HAE attack frequency as “annual” (several attacks annually), “monthly” (several attacks monthly) or “weekly” (several attacks weekly). Multiple linear regression analyses were conducted on the relationship between independent parameters (sex, age, attack frequency, HAE type, and HADS scores) and dependent parameters (AE‐QoL and SF‐12 scores). Fifty‐four patients reported PROMs. All PROMs showed substantial health‐related quality of life (HRQoL) impairment. Overall, the higher the attack frequencies, the greater the reported impairment in the PROMs tended to be. In multiple linear regression analyses, higher AE‐QoL Fatigue/Mood and Fears/Shame domain scores (greater impairment) were associated with higher HADS anxiety subscale scores; higher AE‐QoL total scores (greater HRQoL impairment) and lower SF‐12 Physical and Mental Health Composite scores (greater general health impairment) were associated with higher HADS depression subscale scores. Patients with monthly or weekly HAE attacks reported numerically low absenteeism and numerically high presenteeism and work productivity loss as measured by the WPAI:SHP questionnaire. In this study, conducted before modern LTP options were available in Japan, patients with HAE reported notable impairment in HRQoL and work productivity. Weekly or monthly HAE attack frequencies were associated with a high disease burden. Furthermore, a substantial number of patients reported notable fatigue/mood impairment as measured by the AE‐QoL and depression as measured by the HADS regardless of attack frequency. These results provide a basis for future studies evaluating the effect of LTP on the clinical manifestations and HRQoL in patients with HAE.
遗传性血管性水肿(HAE)的症状千差万别。疾病负担评估对于为患者提供适当的治疗至关重要。患者报告的结果测量(PROMs)包括 12 项简表健康调查(SF-12)、血管性水肿生活质量(AE-QoL)、医院焦虑抑郁量表(HADS)以及工作效率和活动障碍:这些问卷是在2021年收集的,当时日本还没有获得用于HAE长期预防(LTP)的现代药物许可。患者还以 "年"(每年发作数次)、"月"(每月发作数次)或 "周"(每周发作数次)为单位报告其HAE发作频率。对自变量(性别、年龄、发作频率、HAE 类型和 HADS 评分)与因变量(AE-QoL 和 SF-12 评分)之间的关系进行了多元线性回归分析。54 名患者报告了 PROMs。所有 PROM 均显示与健康相关的生活质量(HRQoL)严重受损。总体而言,发作频率越高,所报告的 PROMs 受损程度往往越大。在多元线性回归分析中,较高的 AE-QoL 疲劳/情绪和恐惧/羞耻领域得分(损伤程度更大)与较高的 HADS 焦虑分量表得分相关;较高的 AE-QoL 总分(较高的 HRQoL 损伤程度)和较低的 SF-12 身心健康综合得分(较高的一般健康损伤程度)与较高的 HADS 抑郁分量表得分相关。根据WPAI:SHP问卷调查,每月或每周HAE发作的患者缺勤率较低,旷工率和工作效率损失较高。在这项研究中,HAE 患者的 HRQoL 和工作效率明显受损。HAE 每周或每月的发作频率与较高的疾病负担有关。此外,无论发作频率如何,相当多的患者都报告了明显的疲劳/情绪损害(用 AE-QoL 测量)和抑郁(用 HADS 测量)。这些结果为今后评估 LTP 对 HAE 患者临床表现和 HRQoL 的影响的研究提供了依据。
{"title":"Analysis of disease burden in patients with hereditary angioedema from Japan by patient‐reported outcomes","authors":"Michihiro Hide, Miwa Kishimoto, Ippei Kotera, Akinori Oh, Yoichi Inoue, Beverley Anne Yamamoto, Shinichi Noto","doi":"10.1111/1346-8138.17421","DOIUrl":"https://doi.org/10.1111/1346-8138.17421","url":null,"abstract":"Hereditary angioedema (HAE) symptoms can vary greatly. Disease burden evaluation is essential for providing adequate treatments for patients. Patient‐reported outcome measures (PROMs), including the 12‐Item Short Form Health Survey (SF‐12), the Angioedema Quality of Life (AE‐QoL), the Hospital Anxiety and Depression Scale (HADS), and the Work Productivity and Activity Impairment: Specific Health Problem (WPAI:SHP) questionnaires, were collected in 2021, before modern medications for long‐term prophylaxis (LTP) of HAE were licensed in Japan. Patients also reported their HAE attack frequency as “annual” (several attacks annually), “monthly” (several attacks monthly) or “weekly” (several attacks weekly). Multiple linear regression analyses were conducted on the relationship between independent parameters (sex, age, attack frequency, HAE type, and HADS scores) and dependent parameters (AE‐QoL and SF‐12 scores). Fifty‐four patients reported PROMs. All PROMs showed substantial health‐related quality of life (HRQoL) impairment. Overall, the higher the attack frequencies, the greater the reported impairment in the PROMs tended to be. In multiple linear regression analyses, higher AE‐QoL Fatigue/Mood and Fears/Shame domain scores (greater impairment) were associated with higher HADS anxiety subscale scores; higher AE‐QoL total scores (greater HRQoL impairment) and lower SF‐12 Physical and Mental Health Composite scores (greater general health impairment) were associated with higher HADS depression subscale scores. Patients with monthly or weekly HAE attacks reported numerically low absenteeism and numerically high presenteeism and work productivity loss as measured by the WPAI:SHP questionnaire. In this study, conducted before modern LTP options were available in Japan, patients with HAE reported notable impairment in HRQoL and work productivity. Weekly or monthly HAE attack frequencies were associated with a high disease burden. Furthermore, a substantial number of patients reported notable fatigue/mood impairment as measured by the AE‐QoL and depression as measured by the HADS regardless of attack frequency. These results provide a basis for future studies evaluating the effect of LTP on the clinical manifestations and HRQoL in patients with HAE.","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142176792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspectives of Japanese patients on psoriatic disease burden: Results from “Psoriasis and Beyond,” the Global Psoriatic Disease Survey 日本患者对银屑病疾病负担的看法:全球银屑病调查 "银屑病及其他 "的结果
Pub Date : 2024-09-10 DOI: 10.1111/1346-8138.17424
Masanori Okuse, Masayuki Soekawa, Asako Itakura, Taisuke Kawamura, Sicily Mburu, Susan Frade, Yukari Okubo
Psoriatic disease (PsD) is a chronic disease affecting skin (psoriasis) and joints (psoriatic arthritis, PsA) that has a significant impact on patients' quality of life (QOL). We report findings from the Japanese subgroup of patients included in Psoriasis and Beyond: The Global Psoriatic Disease Survey, a cross‐sectional, quantitative online survey of patients with self‐reported, healthcare professional (HCP)‐diagnosed, moderate‐to‐severe plaque psoriasis, with or without PsA. Eligible patients who were recruited online completed a 25‐min internet‐based survey in Japanese. We assessed patients' understanding of the systemic nature of PsD, disease burden, perception towards their HCPs, treatment expectations, and satisfaction with care. Of the 148 patients, 74% were females. In total, 65% of patients were aware of the systemic nature of their disease. A minority of patients (27%) were aware that PsA was related to their psoriasis, and 30% and 42% of patients were unaware of any manifestations and comorbidities, respectively, related to PsD. Overall, 21% of patients reported that their disease has a “very large” to “extremely large” impact on their QOL (assessed by Dermatology Life Quality Index score), while the majority (61%) reported a “small” effect or “no effect” at all on QOL. Patients experienced stigma and discrimination and had a negative impact on relationships due to PsD. More patients with psoriasis and concomitant PsA (66%) were satisfied with their current treatment than those with psoriasis alone (46%). Overall, 41% of patients were not involved in deciding their treatment goals. These results suggest that Japanese patients may not be fully aware of the systemic nature of PsD, its manifestations and comorbidities. While these patients were somewhat satisfied with their current treatment, they were only occasionally consulted in deciding treatment goals. Policy measures are required to address the stigma and discrimination experienced by patients. Increased patient participation in their care supports shared decision‐making and enhanced treatment outcomes.
银屑病(PsD)是一种影响皮肤(银屑病)和关节(银屑病关节炎,PsA)的慢性疾病,对患者的生活质量(QOL)有很大影响。我们报告了 "银屑病及其他 "全球银屑病疾病调查中日本亚组患者的调查结果:全球银屑病调查 "是一项横断面定量在线调查,调查对象为自我报告、医护人员 (HCP) 诊断为中重度斑块状银屑病、伴有或不伴有 PsA 的患者。通过网络招募的合格患者用日语完成了 25 分钟的网络调查。我们评估了患者对银屑病系统性本质的理解、疾病负担、对其主治医生的看法、对治疗的期望以及对护理的满意度。在 148 名患者中,74% 为女性。总共有 65% 的患者意识到其疾病的系统性。少数患者(27%)知道 PsA 与银屑病有关,分别有 30% 和 42% 的患者不知道与 PsD 有关的任何表现和合并症。总体而言,21% 的患者表示他们的疾病对他们的生活质量有 "非常大 "到 "极大 "的影响(通过皮肤病生活质量指数评分进行评估),而大多数患者(61%)表示对生活质量的影响 "很小 "或 "没有影响"。患者因银屑病而遭受耻辱和歧视,并对人际关系产生负面影响。对当前治疗感到满意的银屑病合并 PsA 患者(66%)多于单纯银屑病患者(46%)。总体而言,41% 的患者没有参与决定他们的治疗目标。这些结果表明,日本患者可能没有充分认识到银屑病的系统性、其表现形式和合并症。虽然这些患者对目前的治疗有些满意,但在决定治疗目标时,他们只是偶尔被咨询。需要采取政策措施来解决患者遭受的耻辱和歧视。患者更多地参与治疗有助于共同决策和提高治疗效果。
{"title":"Perspectives of Japanese patients on psoriatic disease burden: Results from “Psoriasis and Beyond,” the Global Psoriatic Disease Survey","authors":"Masanori Okuse, Masayuki Soekawa, Asako Itakura, Taisuke Kawamura, Sicily Mburu, Susan Frade, Yukari Okubo","doi":"10.1111/1346-8138.17424","DOIUrl":"https://doi.org/10.1111/1346-8138.17424","url":null,"abstract":"Psoriatic disease (PsD) is a chronic disease affecting skin (psoriasis) and joints (psoriatic arthritis, PsA) that has a significant impact on patients' quality of life (QOL). We report findings from the Japanese subgroup of patients included in Psoriasis and Beyond: The Global Psoriatic Disease Survey, a cross‐sectional, quantitative online survey of patients with self‐reported, healthcare professional (HCP)‐diagnosed, moderate‐to‐severe plaque psoriasis, with or without PsA. Eligible patients who were recruited online completed a 25‐min internet‐based survey in Japanese. We assessed patients' understanding of the systemic nature of PsD, disease burden, perception towards their HCPs, treatment expectations, and satisfaction with care. Of the 148 patients, 74% were females. In total, 65% of patients were aware of the systemic nature of their disease. A minority of patients (27%) were aware that PsA was related to their psoriasis, and 30% and 42% of patients were unaware of any manifestations and comorbidities, respectively, related to PsD. Overall, 21% of patients reported that their disease has a “very large” to “extremely large” impact on their QOL (assessed by Dermatology Life Quality Index score), while the majority (61%) reported a “small” effect or “no effect” at all on QOL. Patients experienced stigma and discrimination and had a negative impact on relationships due to PsD. More patients with psoriasis and concomitant PsA (66%) were satisfied with their current treatment than those with psoriasis alone (46%). Overall, 41% of patients were not involved in deciding their treatment goals. These results suggest that Japanese patients may not be fully aware of the systemic nature of PsD, its manifestations and comorbidities. While these patients were somewhat satisfied with their current treatment, they were only occasionally consulted in deciding treatment goals. Policy measures are required to address the stigma and discrimination experienced by patients. Increased patient participation in their care supports shared decision‐making and enhanced treatment outcomes.","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142176726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HPV 51‐associated inguinal SCC on an atopic dermatitis patient treated with cyclosporine 一名接受环孢素治疗的特应性皮炎患者腹股沟 SCC 与 HPV 51 相关
Pub Date : 2024-09-10 DOI: 10.1111/1346-8138.17454
Tomotaka Sato, Manabu Nakazono, Keita Ohyachi, Aya Okaniwa, Hisashi Kobayashi, Kazuto Yamazaki
{"title":"HPV 51‐associated inguinal SCC on an atopic dermatitis patient treated with cyclosporine","authors":"Tomotaka Sato, Manabu Nakazono, Keita Ohyachi, Aya Okaniwa, Hisashi Kobayashi, Kazuto Yamazaki","doi":"10.1111/1346-8138.17454","DOIUrl":"https://doi.org/10.1111/1346-8138.17454","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142176727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploratory study on short‐term administration of oral fosravuconazole for tinea pedis 关于短期口服福斯拉康唑治疗足癣的探索性研究
Pub Date : 2024-09-10 DOI: 10.1111/1346-8138.17455
Yuichiro Tsunemi, Wataru Naka
We investigated the clinical efficacy of short‐term, oral fosravuconazole (F‐RVCZ) therapy for tinea pedis, commonly known as athlete's foot. F‐RVCZ (equivalent to 100 mg ravuconazole) was administered orally once daily for 1 week for interdigital and vesicular tinea pedis and for 4 weeks for hyperkeratotic tinea pedis. Efficacy was evaluated based on mycological efficacy and clinical symptoms at Weeks 1, 4, and 8 for interdigital and vesicular tinea pedis and at Weeks 4, 8, and 12 for hyperkeratotic tinea pedis. Efficacy was confirmed at the end of treatment. Therapeutic efficacy increased over time from the end of treatment for both types of tinea pedis. All adverse drug reactions (ADRs) were within expectations and there were no cases of discontinuation due to ADRs or serious ADRs. Short‐term oral F‐RVCZ therapy is expected to be as effective or more effective than terbinafine and itraconazole, which have already been approved in Japan and may be a useful option for the treatment of tinea pedis.
我们研究了短期口服福斯拉康唑(F-RVCZ)治疗脚癣(俗称香港脚)的临床疗效。F-RVCZ(相当于 100 毫克雷武康唑)每天口服一次,治疗趾间癣和水泡型足癣 1 周,治疗角化过度型足癣 4 周。根据霉菌学疗效和临床症状,在第 1、4 和 8 周对足间癣和水泡型足癣进行疗效评估,在第 4、8 和 12 周对角化过度型足癣进行疗效评估。疗效在治疗结束时得到确认。两种类型的足癣疗效均在治疗结束后随时间推移而增加。所有药物不良反应(ADR)均在预期范围内,没有因药物不良反应或严重药物不良反应而停药的病例。预计短期口服 F-RVCZ 的疗效与特比萘芬和伊曲康唑相同或更佳,这两种药物已在日本获得批准,可能是治疗足癣的有效选择。
{"title":"Exploratory study on short‐term administration of oral fosravuconazole for tinea pedis","authors":"Yuichiro Tsunemi, Wataru Naka","doi":"10.1111/1346-8138.17455","DOIUrl":"https://doi.org/10.1111/1346-8138.17455","url":null,"abstract":"We investigated the clinical efficacy of short‐term, oral fosravuconazole (F‐RVCZ) therapy for tinea pedis, commonly known as athlete's foot. F‐RVCZ (equivalent to 100 mg ravuconazole) was administered orally once daily for 1 week for interdigital and vesicular tinea pedis and for 4 weeks for hyperkeratotic tinea pedis. Efficacy was evaluated based on mycological efficacy and clinical symptoms at Weeks 1, 4, and 8 for interdigital and vesicular tinea pedis and at Weeks 4, 8, and 12 for hyperkeratotic tinea pedis. Efficacy was confirmed at the end of treatment. Therapeutic efficacy increased over time from the end of treatment for both types of tinea pedis. All adverse drug reactions (ADRs) were within expectations and there were no cases of discontinuation due to ADRs or serious ADRs. Short‐term oral F‐RVCZ therapy is expected to be as effective or more effective than terbinafine and itraconazole, which have already been approved in Japan and may be a useful option for the treatment of tinea pedis.","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142176728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coexistence of Basan syndrome and cutaneous basal cell carcinoma: Genetic and clinical perspectives 巴桑综合征与皮肤基底细胞癌并存:遗传与临床视角
Pub Date : 2024-09-10 DOI: 10.1111/1346-8138.17443
Zhijie Luo, Yansi Lyu, Wenwu Dong, Zhongxi Mei, Huijun Wang, Fang Yang
{"title":"Coexistence of Basan syndrome and cutaneous basal cell carcinoma: Genetic and clinical perspectives","authors":"Zhijie Luo, Yansi Lyu, Wenwu Dong, Zhongxi Mei, Huijun Wang, Fang Yang","doi":"10.1111/1346-8138.17443","DOIUrl":"https://doi.org/10.1111/1346-8138.17443","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142176725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "Erythema nodosum in northern Finland between 1996 and 2019: A register-based study". 更正 "1996 年至 2019 年芬兰北部的结节性红斑:一项基于登记的研究"。
Pub Date : 2024-09-06 DOI: 10.1111/1346-8138.17447
{"title":"Correction to \"Erythema nodosum in northern Finland between 1996 and 2019: A register-based study\".","authors":"","doi":"10.1111/1346-8138.17447","DOIUrl":"https://doi.org/10.1111/1346-8138.17447","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142142263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort. 早期重度系统性硬化症临床特征的预测因素:日本多中心前瞻性观察队列分析。
Pub Date : 2024-09-05 DOI: 10.1111/1346-8138.17403
Saori Uesugi-Uchida, Manabu Fujimoto, Yoshihide Asano, Hirahito Endo, Daisuke Goto, Masatoshi Jinnin, Yasushi Kawaguchi, Sumiaki Tanaka, Takahiro Tokunaga, Katsunari Makino, Takashi Matsushita, Sei-Ichiro Motegi, Ayumi Yoshizaki, Shinichi Sato, Minoru Hasegawa

As the clinical course of systemic sclerosis (SSc) varies widely, prognostic indicators have been sought to predict the outcomes of individual patients. Racial differences in SSc render it necessary to validate prognostic indicators in different patient cohorts. In this study, we aimed to assess clinical and laboratory parameters in Japanese patients with early-stage SSc with diffuse cutaneous involvement and/or interstitial lung disease, and identify predictive factors for disease progression. We performed multivariate analyses of baseline clinical information to estimate symptoms 4 years later in Japanese patients with diffuse cutaneous SSc and/or SSc with interstitial lung disease. Patients were enrolled in the study within 5 years of disease onset at 10 Japanese SSc centers. Over 12 years, 115 patients followed up for 4 years were included in this study. The modified Rodnan skin score (mRSS) at 4 years correlated with the baseline mRSS and finger-to-palm distance, defined as the average length from the distal tip of the fourth finger to the distal palmar crease. The percentage predicted vital capacity (%VC) in year 4 positively and negatively correlated with initial %VC and the presence of anti-topoisomerase I antibodies, respectively. The Health Assessment Questionnaire Disability Index (HAQ-DI) at 4 years was positively and negatively associated with baseline HAQ-DI and %VC, respectively. The occurrence of digital ulcers within 4 years was associated with the initial presence of digital ulcers, finger-to-palm distance, and the presence of digital pitting scars and anti-topoisomerase I antibodies. This study identified several factors that may predict the progression of early-stage SSc in Japanese patients. Finger-to-palm distance may be a useful tool for predicting the progression of skin thickening and the development of digital ulcers in the early stages of severe SSc, but larger, long-term prospective studies are needed to confirm our findings.

由于系统性硬化症(SSc)的临床过程千差万别,人们一直在寻找预后指标来预测个体患者的预后。由于系统性硬化症的种族差异,有必要在不同的患者群体中验证预后指标。在这项研究中,我们旨在评估患有弥漫性皮肤受累和/或间质性肺病的早期 SSc 日本患者的临床和实验室参数,并确定疾病进展的预测因素。我们对基线临床信息进行了多变量分析,以估计弥漫性皮肤SSc和/或SSc伴间质性肺病的日本患者4年后的症状。日本 10 家 SSc 中心在患者发病 5 年内将其纳入研究。在 12 年的时间里,本研究共纳入了 115 名随访 4 年的患者。4 年后的改良罗德南皮肤评分(mRSS)与基线 mRSS 和指掌距离相关,指掌距离是指从四指远端到远端掌皱襞的平均长度。第 4 年的预测生命容量百分比(%VC)分别与初始生命容量百分比和抗拓扑异构酶 I 抗体的存在呈正相关和负相关。4年后的健康评估问卷残疾指数(HAQ-DI)分别与基线HAQ-DI和%VC呈正相关和负相关。4 年内出现的数字溃疡与最初出现的数字溃疡、手指到手掌的距离、数字点状疤痕和抗拓扑异构酶 I 抗体有关。这项研究发现了一些可预测日本患者早期 SSc 病情发展的因素。手指到手掌的距离可能是预测严重 SSc 早期皮肤增厚进展和出现数字溃疡的有用工具,但还需要更大规模的长期前瞻性研究来证实我们的发现。
{"title":"Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort.","authors":"Saori Uesugi-Uchida, Manabu Fujimoto, Yoshihide Asano, Hirahito Endo, Daisuke Goto, Masatoshi Jinnin, Yasushi Kawaguchi, Sumiaki Tanaka, Takahiro Tokunaga, Katsunari Makino, Takashi Matsushita, Sei-Ichiro Motegi, Ayumi Yoshizaki, Shinichi Sato, Minoru Hasegawa","doi":"10.1111/1346-8138.17403","DOIUrl":"https://doi.org/10.1111/1346-8138.17403","url":null,"abstract":"<p><p>As the clinical course of systemic sclerosis (SSc) varies widely, prognostic indicators have been sought to predict the outcomes of individual patients. Racial differences in SSc render it necessary to validate prognostic indicators in different patient cohorts. In this study, we aimed to assess clinical and laboratory parameters in Japanese patients with early-stage SSc with diffuse cutaneous involvement and/or interstitial lung disease, and identify predictive factors for disease progression. We performed multivariate analyses of baseline clinical information to estimate symptoms 4 years later in Japanese patients with diffuse cutaneous SSc and/or SSc with interstitial lung disease. Patients were enrolled in the study within 5 years of disease onset at 10 Japanese SSc centers. Over 12 years, 115 patients followed up for 4 years were included in this study. The modified Rodnan skin score (mRSS) at 4 years correlated with the baseline mRSS and finger-to-palm distance, defined as the average length from the distal tip of the fourth finger to the distal palmar crease. The percentage predicted vital capacity (%VC) in year 4 positively and negatively correlated with initial %VC and the presence of anti-topoisomerase I antibodies, respectively. The Health Assessment Questionnaire Disability Index (HAQ-DI) at 4 years was positively and negatively associated with baseline HAQ-DI and %VC, respectively. The occurrence of digital ulcers within 4 years was associated with the initial presence of digital ulcers, finger-to-palm distance, and the presence of digital pitting scars and anti-topoisomerase I antibodies. This study identified several factors that may predict the progression of early-stage SSc in Japanese patients. Finger-to-palm distance may be a useful tool for predicting the progression of skin thickening and the development of digital ulcers in the early stages of severe SSc, but larger, long-term prospective studies are needed to confirm our findings.</p>","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of hidradenitis suppurativa (HS) with waist circumference: A bidirectional two-sample Mendelian randomization study of HS with metabolic syndrome. 化脓性扁桃体炎(HS)与腰围的关系:一项关于化脓性扁桃体炎与代谢综合征的双向双样本孟德尔随机研究。
Pub Date : 2024-09-04 DOI: 10.1111/1346-8138.17436
Huaiyu Wang, Baofeng Wu, Min Luo, Yue Han, Jinhua Chen, Jingjing Liu, Lihang Lin, Xuemin Xiao

Observational studies have suggested an associations between hidradenitis suppurativa (HS) and metabolic syndrome (MetS) and its components. However, it remains unclear whether the relationship is causal or not. Our study aimed to investigate the causal association of HS with MetS and its components. We performed a bidirectional, two-sample Mendelian randomization study using summary-level data from the most comprehensive genome-wide association studies of HS (n = 362 071), MetS (n = 291 107), waist circumference (n = 462 166), hypertension (n = 463 010) fasting blood glucose (FBG, n = 200 622), triglycerides (n = 441 016), and high-density lipoprotein cholesterol (HDL-C, n = 403 943). Genetic instrumental variables were constructed by identifying single nucleotide polymorphisms associated with the corresponding factors. The random-effects inverse-variance weighted method was applied as the primary method. The results showed that genetically predicted HS was positively associated with waist circumference risk in both directions. High waist circumference increased the risk of HS (odds ratio [OR] 4.147; 95% confidence interval [CI] 2.610-6.590; p = 1.746 × 10-9). In addition, HS was also affected by waist circumference (OR 1.009; 95% CI 1.006-1.012; p = 3.08 × 10-7). No causal relationships were found between HS and MetS or its components other than waist circumference. The findings highlight the importance of early intervention for obesity in HS patients. Further studies are needed to determine the pathophysiology of HS associated with MetS and its components.

观察性研究表明,化脓性扁桃体炎(HS)与代谢综合征(MetS)及其组成部分之间存在关联。然而,这种关系是否是因果关系仍不清楚。我们的研究旨在调查 HS 与 MetS 及其组成部分之间的因果关系。我们使用最全面的全基因组关联研究的汇总数据,对 HS(n = 362 071)、MetS(n = 291 107)、腰围(n = 462 166)、高血压(n = 463 010)、空腹血糖(FBG,n = 200 622)、甘油三酯(n = 441 016)和高密度脂蛋白胆固醇(HDL-C,n = 403 943)进行了双向、双样本孟德尔随机化研究。通过识别与相应因子相关的单核苷酸多态性,构建了遗传工具变量。采用随机效应逆方差加权法作为主要方法。结果显示,遗传预测的 HS 与腰围风险呈双向正相关。高腰围会增加罹患 HS 的风险(几率比 [OR] 4.147;95% 置信区间 [CI]2.610-6.590;P = 1.746 × 10-9)。此外,腰围也会影响 HS(OR 1.009;95% CI 1.006-1.012;P = 3.08 × 10-7)。除腰围外,未发现 HS 与 MetS 或其组成部分之间存在因果关系。研究结果凸显了对 HS 患者肥胖进行早期干预的重要性。要确定HS与MetS及其组成部分之间的病理生理学关系,还需要进一步的研究。
{"title":"Association of hidradenitis suppurativa (HS) with waist circumference: A bidirectional two-sample Mendelian randomization study of HS with metabolic syndrome.","authors":"Huaiyu Wang, Baofeng Wu, Min Luo, Yue Han, Jinhua Chen, Jingjing Liu, Lihang Lin, Xuemin Xiao","doi":"10.1111/1346-8138.17436","DOIUrl":"https://doi.org/10.1111/1346-8138.17436","url":null,"abstract":"<p><p>Observational studies have suggested an associations between hidradenitis suppurativa (HS) and metabolic syndrome (MetS) and its components. However, it remains unclear whether the relationship is causal or not. Our study aimed to investigate the causal association of HS with MetS and its components. We performed a bidirectional, two-sample Mendelian randomization study using summary-level data from the most comprehensive genome-wide association studies of HS (n = 362 071), MetS (n = 291 107), waist circumference (n = 462 166), hypertension (n = 463 010) fasting blood glucose (FBG, n = 200 622), triglycerides (n = 441 016), and high-density lipoprotein cholesterol (HDL-C, n = 403 943). Genetic instrumental variables were constructed by identifying single nucleotide polymorphisms associated with the corresponding factors. The random-effects inverse-variance weighted method was applied as the primary method. The results showed that genetically predicted HS was positively associated with waist circumference risk in both directions. High waist circumference increased the risk of HS (odds ratio [OR] 4.147; 95% confidence interval [CI] 2.610-6.590; p = 1.746 × 10<sup>-9</sup>). In addition, HS was also affected by waist circumference (OR 1.009; 95% CI 1.006-1.012; p = 3.08 × 10<sup>-7</sup>). No causal relationships were found between HS and MetS or its components other than waist circumference. The findings highlight the importance of early intervention for obesity in HS patients. Further studies are needed to determine the pathophysiology of HS associated with MetS and its components.</p>","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of one-step and two-step full thickness skin grafting and secondary intention healing for skin defects after surgical management of plantar malignant melanoma. 对足底恶性黑色素瘤手术治疗后皮肤缺损的一步法和两步法全厚植皮与二次意向愈合进行比较分析。
Pub Date : 2024-09-04 DOI: 10.1111/1346-8138.17398
Hiroshi Kato, Shinji Kano, Maki Yoshimitsu, Yua Nakagawa, Yukiko Yasui, Motoki Nakamura, Akimichi Morita

Plantar malignant melanoma is largely managed surgically, particularly in its early stages. However, the plantar region has a lower survival rate of skin grafts than other regions. Furthermore, complete wound healing occurs over a long period of time, postoperatively. Thus, in this study, we retrospectively analyzed the use of skin grafts to reconstruct skin defects, as postoperative complications of plantar malignant melanoma. Forty-nine patients, (23 males, 26 females; mean age 70.4-years) underwent excisional surgery for plantar malignant melanoma at our hospital, between March 2018 and December 2022. The time from initial surgery to wound healing was analyzed, using a multivariate Cox proportional hazards model, to identify related factors. We excluded cases with lesions in non-weight-bearing areas and cases with segmental layer grafts, based on multivariate analysis, to eliminate bias when comparing a one-step resection and reconstruction technique to resection followed by waiting for granulation to occur before reconstruction. Patients were categorized into three cohorts. The first and second cohorts had undergone one-step and two-step skin grafting, respectively. Patients in the third cohort underwent secondary intention healing without skin grafting. The results revealed that the factors associated with wound-healing time included a defect size of >1800 mm2, in addition to two-step and split-thickness skin grafting. Therefore, Kaplan-Meier curves were constructed across the three cohorts, based on the data of 37 patients. Nine cases of non-weight-bearing areas and three cases of split-thickness skin grafts were excluded from the original total of 49 patients. The median times from the initial surgery to wound healing were 14.6, 12.0, and 21.9 weeks for the one- and two-step skin grafting and secondary intention healing cohorts, respectively. A statistically significant difference in the treatment time between the skin grafting and secondary intention healing cohorts was observed (p < 0.001) Moreover, a statistically significant difference in the treatment time between the one- and two-step skin grafting cohorts was noted (p = 0.046). Thus, two-step skin grafting after surgical treatment for plantar malignant melanoma may shorten the overall treatment duration by allowing granulation to occur.

足底恶性黑色素瘤主要通过手术治疗,尤其是在早期阶段。然而,足底区域植皮的存活率低于其他区域。此外,伤口完全愈合需要术后很长一段时间。因此,在本研究中,我们回顾性地分析了植皮重建皮肤缺损的使用情况,以及足底恶性黑色素瘤的术后并发症。2018年3月至2022年12月期间,49名患者(23名男性,26名女性;平均年龄70.4岁)在我院接受了足底恶性黑色素瘤切除手术。我们使用多变量考克斯比例危险模型分析了从初次手术到伤口愈合的时间,以确定相关因素。根据多变量分析,我们排除了病变位于非负重区的病例和节段层植皮的病例,以便在比较一步到位的切除和重建技术与切除后等待肉芽生长再重建的技术时消除偏差。患者被分为三组。第一组和第二组患者分别接受了一步式和两步式植皮术。第三组患者在没有植皮的情况下进行了二次意向性愈合。结果显示,与伤口愈合时间相关的因素包括缺损面积大于 1800 平方毫米,以及两步植皮和分层植皮。因此,根据 37 例患者的数据,构建了三组患者的 Kaplan-Meier 曲线。从最初的 49 例患者中剔除了 9 例非负重区患者和 3 例分层厚皮移植患者。从初次手术到伤口愈合的中位时间分别为 14.6 周、12.0 周和 21.9 周。植皮组和二次意向性愈合组的治疗时间差异有统计学意义(p
{"title":"Comparative analysis of one-step and two-step full thickness skin grafting and secondary intention healing for skin defects after surgical management of plantar malignant melanoma.","authors":"Hiroshi Kato, Shinji Kano, Maki Yoshimitsu, Yua Nakagawa, Yukiko Yasui, Motoki Nakamura, Akimichi Morita","doi":"10.1111/1346-8138.17398","DOIUrl":"https://doi.org/10.1111/1346-8138.17398","url":null,"abstract":"<p><p>Plantar malignant melanoma is largely managed surgically, particularly in its early stages. However, the plantar region has a lower survival rate of skin grafts than other regions. Furthermore, complete wound healing occurs over a long period of time, postoperatively. Thus, in this study, we retrospectively analyzed the use of skin grafts to reconstruct skin defects, as postoperative complications of plantar malignant melanoma. Forty-nine patients, (23 males, 26 females; mean age 70.4-years) underwent excisional surgery for plantar malignant melanoma at our hospital, between March 2018 and December 2022. The time from initial surgery to wound healing was analyzed, using a multivariate Cox proportional hazards model, to identify related factors. We excluded cases with lesions in non-weight-bearing areas and cases with segmental layer grafts, based on multivariate analysis, to eliminate bias when comparing a one-step resection and reconstruction technique to resection followed by waiting for granulation to occur before reconstruction. Patients were categorized into three cohorts. The first and second cohorts had undergone one-step and two-step skin grafting, respectively. Patients in the third cohort underwent secondary intention healing without skin grafting. The results revealed that the factors associated with wound-healing time included a defect size of >1800 mm<sup>2</sup>, in addition to two-step and split-thickness skin grafting. Therefore, Kaplan-Meier curves were constructed across the three cohorts, based on the data of 37 patients. Nine cases of non-weight-bearing areas and three cases of split-thickness skin grafts were excluded from the original total of 49 patients. The median times from the initial surgery to wound healing were 14.6, 12.0, and 21.9 weeks for the one- and two-step skin grafting and secondary intention healing cohorts, respectively. A statistically significant difference in the treatment time between the skin grafting and secondary intention healing cohorts was observed (p < 0.001) Moreover, a statistically significant difference in the treatment time between the one- and two-step skin grafting cohorts was noted (p = 0.046). Thus, two-step skin grafting after surgical treatment for plantar malignant melanoma may shorten the overall treatment duration by allowing granulation to occur.</p>","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Journal of dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1